The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio.
Open accessAbstract
We have examined the effects of mildly oxidized LDL and atherosclerosis on the levels of two proteins associated with HDL; apolipoprotein J (apoJ), and paraoxonase (PON). On an atherogenic diet, PON activity decreased by 52%, and apoJ levels increased 2.8-fold in fatty streak susceptible mice, C57BL/6J (BL/6), but not in fatty streak resistant mice, C3H/HeJ (C3H). Plasma PON activity was also significantly decreased, and apoJ levels were markedly increased in apolipoprotein E knockout mice on the chow diet, resulting in a 9.2-fold increase in the apoJ/PON ratio as compared to controls. Furthermore, a dramatic increase in the apoJ/PON ratio (over 100-fold) was observed in LDL receptor knockout mice when they were fed a 0.15%-cholesterol-enriched diet. Injection of mildly oxidized LDL (but not native LDL) into BL/6 mice (but not in C3H mice) on a chow diet resulted in a 59% decrease in PON activity (P < 0.01) and a 3.6-fold increase in apoJ levels (P < 0.01). When an acute phase reaction was induced in rabbits, or the rabbits were placed on an atherogenic diet, hepatic mRNA for apoJ was increased by 2.7-fold and 2.8-fold, respectively. Treatment of HepG2 cells in culture with mildly oxidized LDL (but not native LDL) resulted in reduced mRNA levels for PON (3.0-fold decrease) and increased mRNA levels for apoJ (2.0-fold increase). In normolipidemic patients with angiographically documented coronary artery disease who did not have diabetes and were not on lipid-lowering medication (n = 14), the total cholesterol/HDL cholesterol ratio was 3.1+/-0.9 as compared to 2.9+/-0.4 in the controls (n = 19). This difference was not statistically significant. In contrast, the apoJ/PON ratio was 3.0+/-0.4 in the patients compared to 0.72+/-0.2 in the controls (P < 0.009). In a subset of these normolipidemic patients (n = 5), the PON activity was low (48+/-6.6 versus 98+/-17 U/ml for controls; P < 0.009), despite similar normal HDL levels, and the HDL from these patients failed to protect against LDL oxidation in co-cultures of human artery wall cells. We conclude that: (a) mildly oxidized LDL can induce an increased apoJ/PON ratio, and (b) the apoJ/PON ratio may prove to be a better predictor of atherosclerosis than the total cholesterol/HDL cholesterol ratio.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,221
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
Havel, R. J., Eder, H. A., & Bragdon, J. H. (1955) · Journal of Clinical Investigation · doi:10.1172/jci103182 · Cited by 8,760
Epstein, F. H., Steinberg, D., Parthasarathy, S., Carew, T. E., Khoo, J. C., & Witztum, J. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198904063201407 · Cited by 6,427
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
Epstein, F. H., Fuster, V., Badimon, L., Badimon, J. J., & Chesebro, J. H. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201303260506 · Cited by 3,725
High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.
Gordon, D. J., Probstfield, J. L., Garrison, R. J., Neaton, J. D., Castelli, W. P., Knoke, J. D., Jacobs, D. R., Bangdiwala, S., & Tyroler, H. A. (1989) · Circulation · doi:10.1161/01.cir.79.1.8 · Cited by 3,162 · cited 1×
“In population studies, the risk for an atherosclerotic event is strongly and inversely related to HDL levels (23).”
BackgroundRole of oxidized low density lipoprotein in atherogenesis.
Witztum, J. L., & Steinberg, D. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115499 · Cited by 2,675
Galis, Z. S., Sukhova, G. K., Lark, M. W., & Libby, P. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117619 · Cited by 2,539
van der Wal, A. C., Becker, A. E., van der Loos, C. M., & Das, P. K. (1994) · Circulation · doi:10.1161/01.cir.89.1.36 · Cited by 1,910
The oxidation hypothesis of atherosclerosis
Witztum, J. L. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92346-9 · Cited by 1,389
Watson, A. D., Berliner, J. A., Hama, S. Y., La Du, B. N., Faull, K. F., Fogelman, A. M., & Navab, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118359 · Cited by 1,154
Self-citationParaoxonase prevents accumulation of lipoperoxides in low‐density lipoprotein
Mackness, M. I., Arrol, S., & Durrington, P. N. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)80962-3 · Cited by 977
Van Lenten, B. J., Hama, S. Y., de Beer, F. C., Stafforini, D. M., McIntyre, T. M., Prescott, S. M., La Du, B. N., Fogelman, A. M., & Navab, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118345 · Cited by 840
Self-citationHigh-density lipoprotein inhibits the oxidative modification of low-density lipoprotein
Parthasarathy, S., Barnett, J., & Fong, L. G. (1990) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(90)90314-n · Cited by 827
MACKNESS, M., ARROL, S., ABBOTT, C., & DURRINGTON, P. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90183-u · Cited by 816
Navab, M., Imes, S. S., Hama, S. Y., Hough, G. P., Ross, L. A., Bork, R. W., Valente, A. J., Berliner, J. A., Drinkwater, D. C., & Laks, H. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115532 · Cited by 737
Self-citationNavab, M., Berliner, J. A., Watson, A. D., Hama, S. Y., Territo, M. C., Lusis, A. J., Shih, D. M., Van Lenten, B. J., Frank, J. S., Demer, L. L., et al. (1996) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.16.7.831 · Cited by 692
Self-citationGan, K. N., Smolen, A., Eckerson, H. W., & La Du, B. N. (1991) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07065-5 · Cited by 596
Self-citationHessler, J. R., Robertson, A. L., & Chisolm, G. M. (1979) · Atherosclerosis · doi:10.1016/0021-9150(79)90166-7 · Cited by 505
Clusterin: Physiologic and pathophysiologic considerations
Rosenberg, M. E., & Silkensen, J. (1995) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/1357-2725(95)00027-m · Cited by 426
Watson, A. D., Navab, M., Hama, S. Y., Sevanian, A., Prescott, S. M., Stafforini, D. M., McIntyre, T. M., Du, B. N., Fogelman, A. M., & Berliner, J. A. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117726 · Cited by 403
Self-citationAbbott, C. A., Mackness, M. I., Kumar, S., Boulton, A. J., & Durrington, P. N. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.11.1812 · Cited by 387
Atherosclerosis in Transgenic Mice Overexpressing Apolipoprotein A-II
Warden, C. H., Hedrick, C. C., Qiao, J.-H., Castellani, L. W., & Lusis, A. J. (1993) · Science · doi:10.1126/science.8332912 · Cited by 360
Self-citationBLATTER, M., JAMES, R. W., MESSMER, S., BARJA, F., & POMETTA, D. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb17620.x · Cited by 347
Serrato, M., & Marian, A. J. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118373 · Cited by 339
Mackness, M. I., Abbott, C., Arrol, S., & Durrington, P. N. (1993) · Biochemical Journal · doi:10.1042/bj2940829 · Cited by 305
Cabana, V. G., Siegel, J. N., & Sabesin, S. M. (1989) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38390-5 · Cited by 300
A Fluorescence-Based Protein Assay for Use with a Microplate Reader
Lorenzen, A., & Kennedy, S. W. (1993) · Analytical Biochemistry · doi:10.1006/abio.1993.1504 · Cited by 292
Role of oxidized low density lipoprotein in atherogenesis
Parthasarathy, S., & Rankin, S. M. (1992) · Progress in Lipid Research · doi:10.1016/0163-7827(92)90006-5 · Cited by 290
Jenne, D. E., Lowin, B., Peitsch, M. C., Böttcher, A., Schmitz, G., & Tschopp, J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99123-4 · Cited by 266
Shih, D. M., Gu, L., Hama, S., Xia, Y. R., Navab, M., Fogelman, A. M., & Lusis, A. J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118589 · Cited by 247
Self-citationDistribution of paraoxon hydrolytic activity in the serum of patients after myocardial infarction.
McElveen, J. E., Mackness, M., COLLEY, C. M., Peard, T., Warner, S., & Walker, C. H. (1986) · Clinical Chemistry · doi:10.1093/clinchem/32.4.671 · Cited by 227
de la Llera Moya, M., Atger, V, Paul, J. L., Fournier, N., Moatti, N., Giral, P., Friday, K. E., & Rothblat, G. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.7.1056 · Cited by 205
Apolipoprotein J expression at fluid-tissue interfaces: potential role in barrier cytoprotection.
Aronow, B. J., Lund, S. D., Brown, T. L., Harmony, J. A., & Witte, D. P. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.725 · Cited by 198
Role of inflammation in coronary plaque disruption.
Buja, L. M., & Willerson, J. T. (1994) · Circulation · doi:10.1161/01.cir.89.1.503 · Cited by 193
Wong, P., Pineault, J., Lakins, J., Taillefer, D., Léger, J., Wang, C., & Tenniswood, M. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53497-9 · Cited by 189
Apolipoprotein J Is Associated with Paraoxonase in Human Plasma
Kelso, G. J., Stuart, W. D., Richter, R. J., Furlong, C. E., Jordan-Starck, T. C., & Harmony, J. A. K. (1994) · Biochemistry · doi:10.1021/bi00169a026 · Cited by 179
French, L. E., Wohlwend, A., Sappino, A. P., Tschopp, J., & Schifferli, J. A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117043 · Cited by 160
Structural and functional diversity of paraoxonases
Du, B. N. L. (1996) · Nature Medicine · doi:10.1038/nm1196-1186 · Cited by 137
Hegele, R. A., Brunt, J., & Connelly, P. W. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.1.89 · Cited by 129
Ohta, T., Takata, K., Horiuchi, S., Morino, Y., & Matsuda, I. (1989) · FEBS Letters · doi:10.1016/0014-5793(89)81590-x · Cited by 126
Purification and characterization of a sulfated glycoprotein secreted by Sertoli cells
Griswold, M. D., Roberts, K. P., & Bishop, P. D. (1986) · Biochemistry · doi:10.1021/bi00371a003 · Cited by 119
Doolittle, M. H., LeBoeuf, R. C., Warden, C. H., Bee, L. M., & Lusis, A. J. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)46234-x · Cited by 104
Self-citationClusterin: modulation of complement function
Tschopp, J., & French, L. E. (1994) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1994.tb06256.x · Cited by 101
Antioxidants and atherosclerosis: A current assessment
Chisolm, G. M. (1991) · Clinical Cardiology · doi:10.1002/clc.4960141304 · Cited by 99
Stafforini, D. M., Zimmerman, G. A., McIntyre, T. M., & Prescott, S. M. (1992) · PubMed · Cited by 90
Mouse apolipoprotein J: characterization of a gene implicated in atherosclerosis.
Jordan-Starck, T. C., Lund, S., Witte, D. P., Aronow, B. J., Ley, C. A., Stuart, W. D., Swertfeger, D. K., Clayton, L., Sells, S. F., & Paigen, B. J. (1994) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41208-8 · Cited by 83
Modified Lipoproteins in the Pathogenesis of Atherosclerosis
Parthasarathy, S. (1994) · Cited by 74
Harðardóttir, I., Kunitake, S. T., Moser, A. H., Doerrler, W. T., Rapp, J. H., Grünfeld, C., & Feingold, K. R. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117449 · Cited by 72
(1993) · PubMed Central · Cited by 68
Identification of the Disulfide Bonds in Human Plasma Protein SP-40,40 (Apolipoprotein-J)1
Choi-Miura, N.-H., Takahashi, Y., Nakano, Y., Tobe, T., & Tomita, M. (1992) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a123938 · Cited by 64
Hepatic apolipoprotein J is secreted as a lipoprotein.
Burkey, B. F., Stuart, W., & Harmony, J. A. K. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41406-3 · Cited by 54
Stress‐induced changes in blood pressure and left ventricular function in mild hypertension
Lindvall, K., Kahan, T., De, U., Östergren, J., & Hjemdahl, P. (1991) · Clinical Cardiology · doi:10.1002/clc.4960140208 · Cited by 45
Cited by
Antiinflammatory Properties of HDL
Barter, P. J., Nicholls, S., Rye, K.-A., Anantharamaiah, G. M., Navab, M., & Fogelman, A. M. (2004) · Circulation Research · doi:10.1161/01.res.0000146094.59640.13 · Cited by 1,394
Self-citationAviram, M., Rosenblat, M., Bisgaier, C. L., Newton, R. S., Primo-Parmo, S. L., & La Du, B. N. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1649 · Cited by 1,168
Self-citationMice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis
Shih, D. M., Gu, L., Xia, Y.-R., Navab, M., Li, W.-F., Hama, S., Castellani, L. W., Furlong, C. E., Costa, L. G., Fogelman, A. M., et al. (1998) · Nature · doi:10.1038/28406 · Cited by 1,078
Self-citationNavab, M., Ananthramaiah, G. M., Reddy, S. T., Van Lenten, B. J., Ansell, B. J., Fonarow, G. C., Vahabzadeh, K., Hama, S., Hough, G., Kamranpour, N., et al. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r400001-jlr200 · Cited by 688
Self-citationNavab, M., Hama, S. Y., Anantharamaiah, G. M., Hassan, K., Hough, G. P., Watson, A. D., Reddy, S. T., Sevanian, A., Fonarow, G. C., & Fogelman, A. M. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33462-3 · Cited by 668
Self-citation
Metadata
- Authors
- Navab, M., Hama-Levy, S., Van Lenten, B. J., Fonarow, G. C., Cardinez, C. J., Castellani, L. W., Brennan, M. L., Lusis, A. J., Fogelman, A. M., & La Du, B. N.
- Venue
- Journal of Clinical Investigation
- Published
- 1997-04-15
- Volume
- 99
- Issue
- 8
- Pages
- 2005-2019
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2069973568
- Cited by
- 309
- References
- 55
- FWCI
- 8.50
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.